Stay updated on Apremilast-Dupilumab Combo in Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast-Dupilumab Combo in Eczema Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer's revision identifier advances from v3.7.1 to v3.7.2. The study page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-18T13:15:25.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:17:13.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed when attempting to view the NCT04306965 record, replacing the study details and navigation. This indicates access restrictions or a broken link preventing the display of the record content.
    Difference
    18%
    Check dated 2026-09-20T10:34:20.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a small maintenance update to the site without altering the study details.
    Difference
    0.1%
    Check dated 2026-08-29T23:55:17.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, signaling a minor backend/template update to the page. This does not change the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T20:52:33.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new version of the page rendering. This reflects a maintenance update without changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-25T12:57:39.000Z thumbnail image

Stay in the know with updates to Apremilast-Dupilumab Combo in Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.